Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

John Messenger to Drug-Eluting Stents

This is a "connection" page, showing publications John Messenger has written about Drug-Eluting Stents.

 
Connection Strength
 
 
 
1.299
 
  1. Kutcher MA, Brennan JM, Rao SV, Dai D, Anstrom KJ, Mustafa N, Sedrakyan A, Sedrakayan A, Booth ME, Douglas PS, Messenger JC. Comparative effectiveness of drug-eluting stents on long-term outcomes in elderly patients treated for in-stent restenosis: a report from the National Cardiovascular Data Registry. Catheter Cardiovasc Interv. 2014 Feb; 83(2):171-81.
    View in: PubMed
    Score: 0.435
  2. Chau KH, Kennedy KF, Messenger JC, Garratt KN, Maddox TM, Yeh RW, Kirtane AJ. Uptake of Drug-Eluting Bioresorbable Vascular Scaffolds in Clinical Practice: An NCDR Registry to Practice Project. JAMA Cardiol. 2019 06 01; 4(6):564-568.
    View in: PubMed
    Score: 0.162
  3. Brennan JM, Sketch MH, Dai D, Trilesskaya M, Al-Hejily W, Rao SV, Brilakis E, Messenger JC, Shaw RE, Anstrom KJ, Peterson ED, Douglas PS. Safety and clinical effectiveness of drug-eluting stents for saphenous vein graft intervention in older individuals: Results from the medicare-linked National Cardiovascular Data Registry(?) CathPCI Registry(?) (2005-2009). Catheter Cardiovasc Interv. 2016 Jan 01; 87(1):43-9.
    View in: PubMed
    Score: 0.124
  4. Hess CN, Rao SV, Dai D, Neely ML, Piana RN, Messenger JC, Peterson ED. Predicting target vessel revascularization in older patients undergoing percutaneous coronary intervention in the drug-eluting stent era. Am Heart J. 2014 Apr; 167(4):576-584.e2.
    View in: PubMed
    Score: 0.111
  5. Patel MR, Marso SP, Dai D, Anstrom KJ, Shunk KA, Curtus JP, Brennan JM, Sedrakyan A, Messenger JC, Douglas PS. Comparative effectiveness of drug-eluting versus bare-metal stents in elderly patients undergoing revascularization of chronic total coronary occlusions: results from the National Cardiovascular Data Registry, 2005-2008. JACC Cardiovasc Interv. 2012 Oct; 5(10):1054-61.
    View in: PubMed
    Score: 0.102
  6. Amin AP, Spertus JA, Cohen DJ, Chhatriwalla A, Kennedy KF, Vilain K, Salisbury AC, Venkitachalam L, Lai SM, Mauri L, Normand SL, Rumsfeld JS, Messenger JC, Yeh RW. Use of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practice. Arch Intern Med. 2012 Aug 13; 172(15):1145-52.
    View in: PubMed
    Score: 0.101
  7. Wang TY, Masoudi FA, Messenger JC, Shunk KA, Boyle A, Brennan JM, Anderson HV, Anstrom KJ, Dai D, Peterson ED, Douglas PS, Rumsfeld JS. Percutaneous coronary intervention and drug-eluting stent use among patients =85 years of age in the United States. J Am Coll Cardiol. 2012 Jan 10; 59(2):105-12.
    View in: PubMed
    Score: 0.097
  8. Rymer JA, Harrison RW, Dai D, Roe MT, Messenger JC, Anderson HV, Peterson ED, Wang TY. Trends in Bare-Metal Stent Use in the United States in Patients Aged =65?Years (from the CathPCI Registry). Am J Cardiol. 2016 10 01; 118(7):959-66.
    View in: PubMed
    Score: 0.033
  9. Wayangankar SA, Bangalore S, McCoy LA, Jneid H, Latif F, Karrowni W, Charitakis K, Feldman DN, Dakik HA, Mauri L, Peterson ED, Messenger J, Roe M, Mukherjee D, Klein A. Temporal Trends and Outcomes of Patients Undergoing Percutaneous Coronary Interventions for Cardiogenic Shock in the Setting of Acute Myocardial Infarction: A Report From the CathPCI Registry. JACC Cardiovasc Interv. 2016 Feb 22; 9(4):341-351.
    View in: PubMed
    Score: 0.032
  10. Kumar RS, Douglas PS, Peterson ED, Anstrom KJ, Dai D, Brennan JM, Hui PY, Booth ME, Messenger JC, Shaw RE. Effect of race and ethnicity on outcomes with drug-eluting and bare metal stents: results in 423 965 patients in the linked National Cardiovascular Data Registry and centers for Medicare & Medicaid services payer databases. Circulation. 2013 Apr 02; 127(13):1395-403.
    View in: PubMed
    Score: 0.026
  11. Baklanov DV, Kaltenbach LA, Marso SP, Subherwal SS, Feldman DN, Garratt KN, Curtis JP, Messenger JC, Rao SV. The prevalence and outcomes of transradial percutaneous coronary intervention for ST-segment elevation myocardial infarction: analysis from the National Cardiovascular Data Registry (2007 to 2011). J Am Coll Cardiol. 2013 Jan 29; 61(4):420-426.
    View in: PubMed
    Score: 0.026
  12. Anderson ML, Peterson ED, Brennan JM, Rao SV, Dai D, Anstrom KJ, Piana R, Popescu A, Sedrakyan A, Messenger JC, Douglas PS. Short- and long-term outcomes of coronary stenting in women versus men: results from the National Cardiovascular Data Registry Centers for Medicare & Medicaid services cohort. Circulation. 2012 Oct 30; 126(18):2190-9.
    View in: PubMed
    Score: 0.025
  13. Tsai TT, Messenger JC, Brennan JM, Patel UD, Dai D, Piana RN, Anstrom KJ, Eisenstein EL, Dokholyan RS, Peterson ED, Douglas PS. Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: a report from the linked CathPCI Registry-CMS claims database. J Am Coll Cardiol. 2011 Oct 25; 58(18):1859-69.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)